首页 | 本学科首页   官方微博 | 高级检索  
     

保肝宁治疗慢性乙型肝炎肝纤维化的临床研究
引用本文:贺松其,张绪富,吕志平,安海燕. 保肝宁治疗慢性乙型肝炎肝纤维化的临床研究[J]. 中华中医药杂志, 2009, 0(5)
作者姓名:贺松其  张绪富  吕志平  安海燕
作者单位:南方医科大学中医药学院;
基金项目:国家自然基金资助课题(No.30672769); 广东省中医药局基金资助课题(No.1050128)
摘    要:目的:观察保肝宁治疗慢性乙型肝炎肝纤维化的疗效。方法:选择慢性乙型肝炎肝纤维化患者228例,随机分为两组:对照组(100例)采用常规保肝治疗,治疗组(128例)在常规治疗的基础上口服保肝宁汤,观察治疗3个月前后两组患者临床症状、体征、肝纤维化血清标志物、纤溶系统指标及影像学指标的变化情况。结果:治疗组对肝炎后肝纤维化患者的临床症状、体征有明显的改善作用,治疗组治疗后低于对照组(P<0.01),两组证候积分治疗前后比较均见显著差异(P<0.01)。治疗组对血清肝纤维化标志物、纤溶系统指标及影像学指标均有明显的改善作用,临床疗效明显优于对照组(P<0.05或P<0.01)。结论:保肝宁具有明显改善肝炎肝纤维化患者的临床症状、体征的作用,且对阻断及逆转肝纤维化进程有一定疗效。

关 键 词:乙型肝炎  肝纤维化  中医药疗法  保肝宁  临床观察  

Clinical research of Baoganning against liver fibrosis after chronic hepatitis B
HE Song-qi,ZHANG Xu-fu,LV Zhi-ping,An Hai-yan. Clinical research of Baoganning against liver fibrosis after chronic hepatitis B[J]. China Journal of Traditional Chinese Medicine and Pharmacy, 2009, 0(5)
Authors:HE Song-qi  ZHANG Xu-fu  LV Zhi-ping  An Hai-yan
Affiliation:HE Song-qi,ZHANG Xu-fu,LV Zhi-ping,An Hai-yan (College of TCM,Southern Medical University,Guangzhou 510515,China)
Abstract:Objective:To observe the effect of Baoganning in the treatment of liver fibrosis after chronic hepatitis B. Methods: 228 cases of such patients were randomly divided into two groups. The control group (100 cases) took the conventional treatment of liver protection, while the treatment group (128 cases) took Baoganning in addition. Then the study observed the clinical symptoms,syndromes, indicators of liver fibrosis, plasminogen activation system and imaging. Results: After treatment, the two groups of patie...
Keywords:Chronic hepatitis B  Liver fibrosis  TCM therapy  Baoganning  Clinical study  
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号